Cite
HARVARD Citation
Taylor, S. et al. (2019). Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial. Lancet. 7 (6), pp. 523-532. [Online].